A COVID-19 vaccine developed by Gaithersburg-based Novavax was recommended Tuesday for those age 18 and older by an advisory panel for the U.S. Centers for Disease Control and Prevention and only awaits final formal approval from CDC. The more traditional vaccine is expected to help overcome some hesitancy among the unvaccinated.